| 000 | 015690000a22003130004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 008 | 060917s2006 ua a f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.08.Ph.D.2006.Mi.O | ||
| 100 | 0 | _aMina Ibrahim Tadros Ayad | |
| 245 | 1 | 0 |
_aOptimization of certain inhaler formulations of an anti asthmatic drug / _cMina Ibrahim Tadros Ayad ; Supervised Ahmed Abdelbary Abdelrahman , Hanan Hossny ElLaithy |
| 246 | 1 | 5 | _aتحسين كفاءة صياغات معينة عن طريق الاستنشاقلعقار مضاد للربوالشعبى |
| 260 |
_aCairo : _bMina Ibrahim Tadros Ayad , _c2006 |
||
| 300 |
_a362 Leaves : _bill ; _c30cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aTraditionally , aerosol drug delivery has been used for modulating the respiratory functions as in the treatment of asthma and local infections of the lung , particularly those giving rise to pneumonia , or occurring in cystic fibrosisRapid drug absorption from aerosols in the lung permits this route to be considered potentially for systemic deliveryThree main delivery systems have been | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAnti-asthmatic | |
| 653 | 4 | _aFormulations | |
| 653 | 4 | _aOptimization | |
| 700 | 0 |
_aAhmed Abdelbary Abdelrahman , _eSupervisor |
|
| 700 | 0 |
_aHanan Hossny ElLaithy , _eSupervisor |
|
| 905 |
_aAml _eCataloger |
||
| 905 |
_aEsam _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42999 _d42999 |
||